[1]
2022. Attributes of intestinal microbiota composition and their correlation with clinical primary non-response to anti-TNF-α agents in inflammatory bowel disease patients. Biomolecules and Biomedicine. 22, 3 (Jun. 2022), 412–426. DOI:https://doi.org/10.17305/bjbms.2021.6436.